Local tetanus begins with a VAMP cleavage-associated neuromuscular junction paralysis around the site of tetanus neurotoxin release.

local tetanus neuromuscular junction neuroparalysis spinal cord tetanus neurotoxin

Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
15 Jun 2024
Historique:
received: 21 03 2024
revised: 14 05 2024
accepted: 23 05 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 17 6 2024
Statut: aheadofprint

Résumé

Local tetanus develops when limited amounts of tetanus neurotoxin (TeNT) are released by Clostridium tetani generated from spores inside a necrotic wound. Within days, a spastic paralysis restricted to the muscles of the affected anatomical area develops. This paralysis follows the retrograde transport of TeNT inside the axons of spinal cord motoneurons and its uptake by inhibitory interneurons with cleavage of VAMP, a synaptic vesicle protein required for neurotransmitter release. Consequently, incontrollable excitation of motoneurons causes contractures of innervated muscles and to local spastic paralysis. Here, the initial events occurring close to the site of TeNT release were investigated in a mouse model of local tetanus. A peripheral flaccid paralysis was found to occur, before or overlapping, the spastic one. At variance from the confined TeNT proteolytic activity at the periphery, central VAMP cleavage can be detected within inhibitory interneurons controlling motor neuron efferents innervating muscle groups distant from the site of TeNT release. These results indicate that TeNT does have a peripheral activity in tetanus and explains why the spastic paralysis observed in local tetanus, although confined to single limbs, generally affects multiple muscles. The initial TeNT neuroparalytic activity can be detected by measuring the compound muscle action potential providing a very early diagnosis and therapy thus preventing the ensuing life-threatening generalized tetanus.

Identifiants

pubmed: 38885925
pii: S0002-9440(24)00208-6
doi: 10.1016/j.ajpath.2024.05.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Federico Fabris (F)

Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy.

Aram Megighian (A)

Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy; Padova Neuroscience Center, University of Padova, Via Giuseppe Orus 2, 35131 Padova, Italy.

Ornella Rossetto (O)

Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy; Center of Myology CIR-Myo, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy; Institute of Neuroscience, National Research Council, Via Ugo Bassi 58/B, 35131 Padova, Italy.

Morena Simonato (M)

Institute of Neuroscience, National Research Council, Via Ugo Bassi 58/B, 35131 Padova, Italy.

Giampietro Schiavo (G)

Department of Neuromuscular Diseases and UCL Queen Square Motor Neuron Disease Centre, UCL Queen Square Institute of Neurology.

Marco Pirazzini (M)

Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy; Center of Myology CIR-Myo, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy. Electronic address: marco.pirazzini@unipd.it.

Cesare Montecucco (C)

Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy; Institute of Neuroscience, National Research Council, Via Ugo Bassi 58/B, 35131 Padova, Italy. Electronic address: cesare.montecucco@unipd.it.

Classifications MeSH